Edition:
United Kingdom

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

0.63USD
19 Oct 2018
Change (% chg)

$-0.00 (-0.44%)
Prev Close
$0.63
Open
$0.61
Day's High
$0.63
Day's Low
$0.60
Volume
18,803
Avg. Vol
124,541
52-wk High
$2.00
52-wk Low
$0.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.152
Mar '18 0.00 -0.201
FY 2017 Dec '17 0.00 -0.356
Sep '17 0.00 -0.385
Jun '17 0.00 -0.592
Mar '17 0.00 -0.477
FY 2016 Dec '16 0.00 -0.467
Sep '16 0.00 -0.514
Jun '16 0.00 -0.430
Mar '16 0.00 -0.403
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 1 -0.22 -0.22 -0.22 --
Quarter Ending Mar-19 1 -0.22 -0.22 -0.22 --
Year Ending Dec-18 1 -0.77 -0.77 -0.77 --
Year Ending Dec-19 1 -1.03 -1.03 -1.03 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.90 33.64
P/E High - Last 5 Yrs. -- 40.57 45.19
P/E Low - Last 5 Yrs. -- 23.27 23.75
Beta 1.86 0.89 0.88
Price to Sales (TTM) -- 3.93 5.83
Price to Book (MRQ) 1.03 4.77 4.89
Price to Tangible Book (MRQ) 1.32 5.60 6.51
Price to Cash Flow (TTM) -- 22.55 22.92
% Owned Institutions 40.03 1.13 2.14

Dividends

  Company industry sector
Dividend Yield -- 1.58 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.41 5.40
Payout Ratio(TTM) -- 46.17 43.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.22 8.10
Sales (TTM) vs TTM 1 Yr. Ago -- 4.64 5.80
Sales - 5 Yr. Growth Rate -- 9.68 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago -37.87 19.50 23.38
EPS (TTM) vs TTM 1 Yr. Ago -37.35 -- --
EPS - 5 Yr. Growth Rate -- 9.94 10.92
Capital Spending - 5 Yr. Growth Rate -8.78 15.08 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.25
Current Ratio (MRQ) 6.61 2.97 3.05
LT Debt to Equity (MRQ) 0.00 9.97 12.76
Total Debt to Equity (MRQ) 0.00 14.00 17.18
Interest Coverage (TTM) -- 41.52 37.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.18 54.87
Gross Margin - 5 Yr. Avg. -- 52.28 52.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.46 11.01
Operating Margin (TTM) -- 14.30 4.07
Operating Margin - 5 Yr. Avg. -- 14.34 6.34
Pre-Tax Margin (TTM) -- 14.85 5.12
Pre-Tax Margin - 5 Yr. Avg. -- 14.78 6.78
Net Profit Margin (TTM) -- 11.07 1.39
Net Profit Margin - 5 Yr. Avg. -- 11.06 3.03
Effective Tax Rate (TTM) -- 23.35 23.24
Effective Tax Rate - 5 Yr. Avg. -- 23.59 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 909,735,120 808,218,600
Net Income/Employee (TTM) -938,150 107,051,698 95,058,584
Receivable Turnover (TTM) -- 5.62 5.78
Inventory Turnover (TTM) -- 2.61 3.63
Asset Turnover (TTM) 0.00 0.94 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -75.16 11.35 10.90
Return on Assets - 5 Yr. Avg. -53.33 12.60 12.01
Return on Investment (TTM) -82.09 14.75 14.27
Return on Investment - 5 Yr. Avg. -57.26 16.42 15.60
Return on Equity (TTM) -82.23 16.24 15.99
Return on Equity - 5 Yr. Avg. -59.65 17.49 16.87
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 0.34 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ARCA Biopharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.00 20.69 99 22
13 Week -42.31 -45.12 9 33
26 Week -36.17 -41.02 22 27
52 Week -46.71 -54.84 20 12
YTD -47.37 -53.78 15 24
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.88%
# of Holders: 24
Total Shares Held: 1,793,968
3 Mo. Net Change: -429
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.